Skip to main content
VCbacked
Log inGet Started

Timberlyne Therapeutics

San Diego, United States

Timberlyne Therapeutics is a biopharmaceutical company that develops therapies for autoimmune diseases.

$180.0M raised
Jan 2025
Series A
BiopharmaBiotechnologyHealth Care

Top Investors

Lilly Asia VenturesAbingworthBain Capital Life Sciences3H Health InvestmentVenrock Healthcare Capital Partners

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Timberlyne Therapeutics

How much funding has Timberlyne Therapeutics raised?
Timberlyne Therapeutics has raised $180.0M in total funding. The most recent round was Series A. The last funding was announced in January 2025.
Who are Timberlyne Therapeutics's investors?
Timberlyne Therapeutics's investors include Lilly Asia Ventures, Abingworth, Bain Capital Life Sciences, 3H Health Investment, Venrock Healthcare Capital Partners.
Where is Timberlyne Therapeutics headquartered?
Timberlyne Therapeutics is headquartered in San Diego, United States.
What does Timberlyne Therapeutics do?
Timberlyne Therapeutics is a biopharmaceutical company that develops therapies for autoimmune diseases.
What stage is Timberlyne Therapeutics at?
Timberlyne Therapeutics is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Timberlyne Therapeutics — Funding & Investors." VCBacked, January 9, 2025, https://www.vcbacked.co/company/timberlyne-therapeutics. Accessed June 16, 2026.
APA
VCBacked. (2025). Timberlyne Therapeutics — Funding & Investors. Retrieved June 16, 2026, from https://www.vcbacked.co/company/timberlyne-therapeutics
Wikipedia (cite web)
{{cite web |title=Timberlyne Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/timberlyne-therapeutics |website=VCBacked |access-date=June 16, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biopharma

View all
ParcelBio
San Francisco$13.2M
Modicus Prime
Austin
Latus Bio
Philadelphia
Ocugen
Malvern
Ember LifeSciences
Los Angeles$16.5M
ClearNote Health
San Diego